A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

References

• GLOBOCAN 2012 (IARC)Stomach Cancer-Estimated Incidence, Mortality and Prevalence Worldwide in 2012GLOBOCAN 2012 (IARC), Section of Cancer Information2012Lyon, France
   Google Scholar
• LambertRSaitoHLucasESankaranarayananRSurvival from digestive cancer in emerging countries in Asia and AfricaEur J Gastroenterol Hepatol201224660561222387886
   PubMed Web of Science ®Google Scholar
• AllemaniCWeirHKCarreiraHCONCORD Working GroupGlobal surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Lancet20153859972977101025467588
   PubMed Web of Science ®Google Scholar
• SpolveratoGEjazAKimYRates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysisJ Am Coll Surg2014219466467525154671
   PubMed Web of Science ®Google Scholar
• BauerKSchroederMPorzsoltFHenne-BrunsDComparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differencesJ Gastric Cancer2015151101825861518
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer AssociationJapanese gastric cancer treatment guidelines 2010 (ver. 3)Gastric Cancer201114211312321573742
   PubMed Web of Science ®Google Scholar
• BangYJKimYWYangHKCLASSIC trial investigatorsAdjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialLancet2012379981331532122226517
   PubMed Web of Science ®Google Scholar
• CaoJQiFLiuTAdjuvant chemotherapy after curative resection for gastric cancer: a meta-analysisScand J Gastroenterol201449669070424731211
   PubMed Web of Science ®Google Scholar
• SakuramotoSSasakoMYamaguchiTACTS-GC GroupAdjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidineN Engl J Med2007357181810182017978289
   PubMed Web of Science ®Google Scholar
• SobinLHWCGospodarowiczMTNM Classification of Malignant Tumors (UICC)737th edNew YorkWileye Blackwell20097
   Google Scholar
• MiceliRTomaselloGBregniGDi BartolomeoMPietrantonioFAdjuvant chemotherapy for gastric cancer: current evidence and future challengesWorld J Gastroenterol201420164516452524782604
   PubMed Web of Science ®Google Scholar
• ZuHWangFMaYXueYStage-stratified analysis of prognostic significance of tumor size in patients with gastric cancerPLoS One201381e5450223382906
   PubMed Web of Science ®Google Scholar
• QuanJZhangRLiangHThe impact of tumor size on survival of patients with pT4aN0M0 gastric cancerAm Surg201379332833123461965
   PubMed Web of Science ®Google Scholar
• LuJHuangCMZhengCHConsideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomySurg Oncol201322316717123787074
   PubMed Web of Science ®Google Scholar
• LiuXXuYLongZZhuHWangYPrognostic significance of tumor size in T3 gastric cancerAnn Surg Oncol20091671875188219373514
   PubMed Web of Science ®Google Scholar
• AoyamaTYoshikawaTWatanabeTMacroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1Gastric Cancer201114327427821461654
   PubMed Web of Science ®Google Scholar
• ImWJKimMGHaTKKwonSJTumor size as a prognostic factor in gastric cancer patientJ Gastric Cancer201212316417223094228
   PubMedGoogle Scholar
• ZhangBYYuanJCuiZSLiZWLiXHLuYYEvaluation of the prognostic value of the metastatic lymph node ratio for gastric cancerAm J Surg2013207455556524124661
   PubMed Web of Science ®Google Scholar
• XuDZGengQRLongZJPositive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodesAnn Surg Oncol200916231932619050970
   PubMed Web of Science ®Google Scholar
• SunZZhuGLLuCThe impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2,159 patientsAnn Oncol200920589790519179553
   PubMed Web of Science ®Google Scholar
• WongJRahmanSSaeedNPrognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experienceJ Gastrointest Surg201317122059206624129828
   PubMed Web of Science ®Google Scholar
• CostaWLJrCoimbraFJFogaroliRCAdjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer centerRadiat Oncol2012716923068190
   PubMed Web of Science ®Google Scholar
• InoueKNakaneYIiyamaHThe superiority of ratio-based lymph node staging in gastric carcinomaAnn Surg Oncol200291273411829427
   PubMed Web of Science ®Google Scholar
• MarchetAMocellinSAmbrosiAItalian Research Group for Gastric Cancer Study (GIRCG)The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter seriesEur J Surg Oncol200834215916517566691
   PubMed Web of Science ®Google Scholar
• MaeharaYSugimachiKAkagiMKakegawaTShimazuHTomitaMSerum carcinoembryonic antigen level increases correlate with tumor progression in patients with differentiated gastric carcinoma following noncurative resectionCancer Res19905013395239552191769
   PubMed Web of Science ®Google Scholar
• MihmanliMDilegeEDemirUCoskunHErogluTUysalolMDThe use of tumor markers as predictors of prognosis in gastric cancerHepatogastroenterology200451591544154715362797
   PubMedGoogle Scholar
• SisikAKayaMBasGBasakFAlimogluOCEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patientsAsian Pac J Cancer Prev20131474289429423991991
   PubMedGoogle Scholar
• AliustaogluMBiliciAUstaaliogluBBThe effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatmentMed Oncol20102741060106519847679
   PubMed Web of Science ®Google Scholar
• UcarESemerciEUstunHYetimTHuzmeliCGulluMPrognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancerAdv Ther200825101075108418821070
   PubMed Web of Science ®Google Scholar
• ParkBWOhJWKimJHPreoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomesAnn Oncol200819467568118037623
   PubMed Web of Science ®Google Scholar
• KoderaYYamamuraYToriiAThe prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancerAm J Gastroenterol199691149538561143
   PubMed Web of Science ®Google Scholar
• KimDYKimHRShimJHParkCSKimSKKimYJSignificance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patientsJ Surg Oncol200074318519210951413
   PubMed Web of Science ®Google Scholar
• LiangYDingXWangXPrognostic value of surgical margin status in gastric cancer patientsANZ J Surg201485967868424438078
   PubMed Web of Science ®Google Scholar
• LiuYChenXHMengXHMultivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?Hepatogastroenterology20125911462362622024039
   PubMedGoogle Scholar
• BiliciASekerMUstaaliogluBBPrognostic significance of perineural invasion in patients with gastric cancer who underwent curative resectionAnn Surg Oncol20101782037204420333555
   PubMed Web of Science ®Google Scholar
• MarrelliDMorgagniPde ManzoniGItalian Research Group for Gastric Cancer (IRGGC)Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centersAnn Surg2012255348649122167003
   PubMed Web of Science ®Google Scholar
• FjortoftIFurnesBHauskenTStorliKEEideGESondenaaKPreoperative anaemia in colon cancer patients became normal after more than a year post-operatively but did not influence oncological outcome in the final analysisScand J Gastroenterol201348666367123534433
   PubMed Web of Science ®Google Scholar
• SpolveratoGEjazAKimYPrognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinomaAnn Surg2015262699199825563867
   PubMed Web of Science ®Google Scholar
• LeeSOhSYKimSHPrognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer20131335023876227
   PubMed Web of Science ®Google Scholar
• DikkenJLJansenEPCatsAImpact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancerJ Clin Oncol201028142430243620368551
   PubMed Web of Science ®Google Scholar
• BickenbachKAGonenMStrongVBrennanMFCoitDGAssociation of positive transection margins with gastric cancer survival and local recurrenceAnn Surg Oncol20132082663266823536054
   PubMed Web of Science ®Google Scholar
• KimYSpolveratoGEjazAA nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinomaAnn Surg Oncol20142261828183525388061
   PubMed Web of Science ®Google Scholar
• KattanMWKarpehMSMazumdarMBrennanMFPostoperative nomogram for disease-specific survival after an R0 resection for gastric carcinomaJ Clin Oncol200321193647365014512396
   PubMed Web of Science ®Google Scholar
• VacantiCJVanHoutenRJHillRCA statistical analysis of the relationship of physical status to postoperative mortality in 68,388 casesAnesth Analg19704945645665534668
   PubMed Web of Science ®Google Scholar
• LiuXCaiHWangYPrognostic significance of tumor markers in T4a gastric cancerWorld J Surg Oncol2012106822540862
   PubMed Web of Science ®Google Scholar
• FrankEHarrellJKerryLLDanielBMTutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsStat Med1996153613878668867
   PubMed Web of Science ®Google Scholar
• BriaEDe ManzoniGBeghelliSA clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression statusAnn Oncol201324369370123131390
   PubMed Web of Science ®Google Scholar
• BoulesteixA-LStroblCMaximally selected chi-squared statistics and non-monotonic associations: an exact approach based on two cutpointsComput Stat Data Anal2007511262956306
   Web of Science ®Google Scholar
• AndrewEBThe use of the area under the roc curve in the evaluation of machine learning algorithmsPattern Recognit199730711451159
   Web of Science ®Google Scholar
• ZhangYWZhangYLPanHChemotherapy for patients with gastric cancer after complete resection: a network meta-analysisWorld J Gastroenterol201420258459224574729
   PubMed Web of Science ®Google Scholar
• GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) GroupPaolettiXObaKBenefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysisJAMA2010303171729173720442389
   PubMed Web of Science ®Google Scholar
• GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) GroupObaKPaolettiXRole of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysisEur J Cancer20134971565157723352439
   PubMed Web of Science ®Google Scholar
• LiuTSWangYChenSYSunYHAn updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancerEur J Surg Oncol200834111208121618353606
   PubMed Web of Science ®Google Scholar
• SasakoMSakuramotoSKataiHFive-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancerJ Clin Oncol201129334387439322010012
   PubMed Web of Science ®Google Scholar
• BeckerKReimDNovotnyAProposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgeryAnn Surg201225661002100722968067
   PubMed Web of Science ®Google Scholar
• ChauINormanARCunninghamDWatersJSOatesJRossPJMultivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer – pooled analysis from three multicenter, randomized, controlled trials using individual patient dataJ Clin Oncol200422122395240315197201
   PubMed Web of Science ®Google Scholar
• KanagavelDPokataevIAFedyaninMYA prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapyAnn Oncol20102191779178520150573
   PubMed Web of Science ®Google Scholar
• DikkenJLBaserREGonenMConditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancerAnn Surg Oncol20132051623163023143591
   PubMed Web of Science ®Google Scholar
• HanDSSuhYSKongSHNomogram predicting long-term survival after d2 gastrectomy for gastric cancerJ Clin Oncol201230313834384023008291
   PubMed Web of Science ®Google Scholar
• ShinoharaTKanayaSTaniguchiKFujitaTYanagaKUyamaILaparoscopic total gastrectomy with D2 lymph node dissection for gastric cancerArch Surg2009144121138114220026832
   PubMedGoogle Scholar
• HuangJLWeiHBZhengZHLaparoscopy-assisted D2 radical distal gastrectomy for advanced gastric cancerDig Surg201027429129620689290
   PubMed Web of Science ®Google Scholar
• ShinoharaTSatohSKanayaSLaparoscopic versus open D2 gastrectomy for advanced gastric cancer: a retrospective cohort studySurg Endosc201327128629422733201
   PubMed Web of Science ®Google Scholar
• LordickFLorenzenSYamadaYIlsonDOptimal chemotherapy for advanced gastric cancer: is there a global consensus?Gastric Cancer201417221322524048758
   PubMed Web of Science ®Google Scholar
• KimSTParkKHOhSCIs chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?Asia Pac J Clin Oncol20128219420022524579
   PubMed Web of Science ®Google Scholar
• KangHKauhJSChemotherapy in the treatment of metastatic gastric cancer: is there a global standard?Curr Treat Options Oncol20111219610621274667
   PubMed Web of Science ®Google Scholar
• SeevaratnamRBocicariuACardosoRHow many lymph nodes should be assessed in patients with gastric cancer? A systematic reviewGastric Cancer201215suppl 1S70S8822895615
   PubMedGoogle Scholar
• TongLLGaoPWangZNCan lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer?Ann Surg Oncol20111892453246021455596
   PubMed Web of Science ®Google Scholar
• CaoQZhangBZhaoLThe impact of positive nodal chain ratio on individualized multimodality therapy in non-small-cell lung cancerTumour Biol20153664617462525623115
   PubMedGoogle Scholar
• BergerACSigurdsonERLeVoyerTColon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodesJ Clin Oncol200523348706871216314630
   PubMed Web of Science ®Google Scholar
• LiQLiGPalmerJDZhangZLymph node burden as a predictive factor for selective chemoradiotherapy in patients with locally advanced gastric cancer after a D2 dissection: a retrospective studyAm J Clin Oncol Epub20141210
   Google Scholar
• JinLXMosesLESquiresMH3rdFactors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: a 7-institution study of the US gastric cancer collaborativeAnn Surg20152626999100525607760
   PubMed Web of Science ®Google Scholar
• ParkJHRyuMHKimHJRisk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancerGastric Cancer Epub2015123
   Web of Science ®Google Scholar
• KunisakiCMakinoHKimuraJImpact of lymphovascu-lar invasion in patients with stage I gastric cancerSurgery2010147220421119878963
   PubMed Web of Science ®Google Scholar
• MacRaeRShyrYJohnsonDChoyHDeclining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significantRadiother Oncol2002641374012208573
   PubMed Web of Science ®Google Scholar
• PangLWangJJiangYChenLDecreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancerExp Ther Med20136235536024137188
   PubMed Web of Science ®Google Scholar
• AnXDingPRXiangXJCarcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapyBiomarkers201015324324820121626
   PubMed Web of Science ®Google Scholar
• HuhJWLeeWYParkYAPrognostic factors associated with primary cancer in curatively resected stage IV colorectal cancerJ Cancer Res Clin Oncol2014140343544124414039
   PubMed Web of Science ®Google Scholar
• SunZZhangNClinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapyWorld J Surg Oncol20141239725543664
   PubMed Web of Science ®Google Scholar
• QiuMZXuRHRuanDYIncidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in ChinaTumour Biol201031663364120652781
   PubMedGoogle Scholar
• GilreathJAStenehjemDDRodgersGMDiagnosis and treatment of cancer-related anemiaAm J Hematol201489220321224532336
   PubMed Web of Science ®Google Scholar
• WuCWHsiehMCLoSSPrognostic indicators for survival after curative resection for patients with carcinoma of the stomachDig Dis Sci1997426126512699201093
   PubMed Web of Science ®Google Scholar
• ShenJGCheongJHHyungWJKimJChoiSHNohSHPretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancerJ Surg Oncol200591212613016028285
   PubMed Web of Science ®Google Scholar
• LimCHKimSWKimWCAnemia after gastrectomy for early gastric cancer: long-term follow-up observational studyWorld J Gastroenterol201218426114611923155340
   PubMed Web of Science ®Google Scholar
• ParkJYKimYJLaparoscopic Roux-en-Y gastric bypass in obese Korean patients: efficacy and potential adverse eventsSurg Today Epub2015426
   Web of Science ®Google Scholar
• ChoiBMKimYMJeongYRInduction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cellsBiochem Biophys Res Commun2004321113213715358225
   PubMed Web of Science ®Google Scholar
• AgarwalABolisettySAdaptive responses to tissue injury: role of heme oxygenase-1Trans Am Clin Climatol Assoc201312411112223874015
   PubMedGoogle Scholar
• FraserSTMidwinterRGCouplandLAHeme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in miceHaematologica2015100560161025682599
   PubMed Web of Science ®Google Scholar
• WaddellTVerheijMAllumWCunninghamDCervantesAArnoldDGastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-upEur J Surg Oncol201440558459124685156
   PubMed Web of Science ®Google Scholar
• SmalleySRBenedettiJKHallerDGUpdated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resectionJ Clin Oncol201230192327233322585691
   PubMed Web of Science ®Google Scholar
• MacdonaldJSSmalleySRBenedettiJChemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionN Engl J Med20013451072573011547741
   PubMed Web of Science ®Google Scholar
• YchouMBoigeVPignonJPPerioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trialJ Clin Oncol201129131715172121444866
   PubMed Web of Science ®Google Scholar
• RonellenfitschUSchwarzbachMHofheinzRGE Adenocarcinoma Meta-analysis GroupPerioperative chemo (radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusCochrane Database Syst Rev20135CD00810723728671
   PubMedGoogle Scholar
• CunninghamDAllumWHStenningSPMAGIC Trial ParticipantsPerioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerN Engl J Med20063551112016822992
   PubMed Web of Science ®Google Scholar
• AllgayerHBabicRGruetznerKUTarabichiASchildbergFWHeissMMc-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systemsJ Clin Oncol200018112201220910829039
   PubMed Web of Science ®Google Scholar
• BegnamiMDFukudaEFregnaniJHPrognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcomeJ Clin Oncol201129223030303621709195
   PubMed Web of Science ®Google Scholar
• LeeHSLeeHKKimHSYangHKKimWHTumour suppressor gene expression correlates with gastric cancer prognosisJ Pathol20032001394612692839
   PubMed Web of Science ®Google Scholar
• KimBByunSJKimYACell cycle regulators, APC/betacatenin, NF-kappaB and Epstein-Barr virus in gastric carcinomasPathology2010421586520025482
   PubMed Web of Science ®Google Scholar
• WuMSShunCTWangHPGenetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infectionGastroenterology19971125145714659136822
   PubMed Web of Science ®Google Scholar
• CorsoGCarvalhoJMarrelliDSomatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancerJ Clin Oncol201331786887523341533
   PubMed Web of Science ®Google Scholar
• WadhwaRSongSLeeJSYaoYWeiQAjaniJAGastric cancer-molecular and clinical dimensionsNat Rev Clin Oncol2013101164365524061039
   PubMed Web of Science ®Google Scholar